Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
The Commission has declared final result of Combined Graduate Level Examinat…
MULTIPLE CHOICE QUESTIONS GENERAL KNOWLEDGE 20 MCQ PRACTICE SET FOR VARIOUS EXAM…